Significant Ownership of Robert Nelsen
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Robert Nelsen focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Chicago, IL
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
CIK context first
Continue from Robert Nelsen
Significant Ownership of Robert Nelsen
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | Common Stock, $0.00001 par value | 10% | $80,853,607 | 18,587,036 | Robert Nelsen | 07 Aug 2025 | ||
| VIR | Vir Biotechnology, Inc. | Common Stock, $0.0001 par value | 7.3% | $147,344,582 | -$12,094,232 | 12,508,029 | -7.6% | Robert Nelsen | 04 Nov 2026 |
Schedules 13D/G Reported by Robert Nelsen:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.